| |
Baseline
|
After 6 weeks
|
After 12 weeks
|
|---|
|
Statin group
|
Combination group
|
Statin group
|
Combination group
|
Statin group
|
Combination group
|
|---|
|
TC (mmol/L)
|
4.85 ± 0.90
|
4.92 ± 0.83
|
4.22 ± 0.88*
|
3.75 ± 0.65 *
|
4.12 ± 0.76†
|
3.39 ± 0.30†§
|
|
TG (mmol/L)
|
1.97 ± 1.02
|
1.91 ± 0.87
|
1.74 ± 0.71*
|
1.24 ± 0.54 *
|
1.62 ± 0.63†
|
1.15 ± 0.48†§
|
|
LDL-C (mmol/L)
|
3.00 ± 0.43
|
3.04 ± 0.46
|
2.30 ± 0.53*
|
2.06 ± 0.28 *
|
2.21 ± 0.55†
|
1.93 ± 0.29†§
|
|
HDL-C (mmol/L)
|
0.89 ± 0.22
|
0.93 ± 0.14
|
1.00 ± 0.26*
|
1.10 ± 0.13 *
|
1.05 ± 0.20†
|
1.14 ± 0.08†§
|
|
ApoA5 (ng/ml)
|
49.49 ± 1.59
|
49.50 ± 2.48
|
61.48 ± 6.00*
|
66.03 ± 8.79*
|
67.4 ± 5.50†
|
73.2 ± 6.67†§
|
|
Hs-CRP (mg/L)
|
3.97 ± 3.52
|
3.89 ± 2.96
|
2.01 ± 0.94*
|
1.61 ± 0.32*
|
2.03 ± 1.54*
|
1.62 ± 0.63*
|
- Note: TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, ApoA5 apolipoprotein A5, hs-CRP high-sensitivity C-reactive protein.
- * p < 0.05, compared with baseline in the same group;
- † p < 0.05, compared with 6 weeks in the same group;
- § p < 0.05, combination group versus statin group by repeated measures ANOVA analyses.
